Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer

Saved in:
Bibliographic Details
Published inBritish Medical Journal (Clinical research ed.) Vol. 291; no. 6488; pp. 105 - 106
Main Authors Vincent, M D, Clink, H M, Coombes, R C, Smith, I E, Kandler, R, Powles, T J
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 13.07.1985
British Medical Association
BMJ Publishing Group LTD
Subjects
Aged
Agranulocytosis
Agranulocytosis - chemically induced
Aminoglutethimide - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Blood counts
Bone marrow
Breast cancer
Breast Neoplasms - blood
Breast Neoplasms - drug therapy
Carcinoma, Intraductal, Noninfiltrating - drug therapy
Drug effects
Female
Humans
Hydrocortisone - therapeutic use
Leukocyte Count
Medical specialists
Middle Aged
Platelet Count
Platelets
Short Reports
Thrombocytosis
Online AccessGet full text

Cover

More Information
Bibliography:PMID:2990631
href:bmj-291-105-2.pdf
istex:E7A29A4BF4B5682E1C55024969B997027EFEDE2F
ark:/67375/NVC-T3NC830H-T
local:bmj;291/6488/105-a
ISSN:0267-0623
1468-5833
DOI:10.1136/bmj.291.6488.105-a